Home / CANCER BUZZ Podcast


Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple PodcastsSpotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Podcast Format

The aging US population is predicted to drive an increase in cancer incidence of almost 50% by 2050. At the same time, some cancer programs face capacity and resource constraints—which will continue to increase as demand for cancer services rises. Many cancer programs are also facing significant challenges with patient access.
Health technology performance and integration of electronic health record (EHR) systems have become critical factors in conducting efficient and equitable biomarker testing at cancer programs nationwide.. Listen in as CancerBuzz speaks to Karen Huelsman, MS, LGC, precision oncology lead and genetic counselor at TriHealth Cancer and Blood Institute, about key takeaways and insights from the Working …
In 2020, this community-based cancer program started laying the foundation for a disease-site specific oncology patient navigation program that would grow exponentially over the next 2 years.
Listen as we discuss germline and somatic testing for patients with ovarian cancer.
Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients with acute myeloid leukemia.
Hear about the evolution of artificial intelligence in precision oncology and the clinical impact of tech-based solutions.
CANCER BUZZ interviews Karline Paul, Associate Operating Officer at Vanderbilt University Medical Center, about the ways technology can support—not replace—the oncology workforce.
ACCC was invited to share the association’s key priorities for impacting cancer care in the US. ACCC president Olalekan Ajayi, PharmD, MBA, and chief operating officer at Highlands Oncology Group, PA, discusses the meeting and these initiatives.
Live this week from the ACCC 40th National Oncology Conference (NOC), CANCER BUZZ interviews Debbie Rimmele, Nurse Retention Specialist at the Loyola University Medical Center, about recruiting strategies and her session at the NOC: Looking Under the Hood of the Employment Process.
Live this week from the ACCC 40th National Oncology Conference (NOC), CANCER BUZZ interviews Steve Kennedy, Senior Vice President of Human Resources at Tennessee Oncology, about his session: Leadership Engagement and Sustainment During Challenging Times.
Live this week from the ACCC 40th National Oncology Conference, CANCER BUZZ interviews Dr. Michael Gieske about best practices to increase lung cancer screenings and ACCC’s Rural Appalachian Lung Screening Initiative.
CANCER BUZZ previews the sessions, people and topics of this week’s ACCC 40th National Oncology Conference. We interview Kathy Oubre, MS, CEO of the Pontchartrain Canter Center, about helping patients overcome access barriers to biomarker testing.
Hear Dr. Margaret Liang, of Cedars-Sinai Cancer Center, Los Angeles, talk about ACCC’s Financial Advocacy Network (FAN) and the Financial Advocacy Services guidelines to help cancer programs address the growing issue of financial toxicity.
Disparities in bladder cancer care persist, especially with respect to race. In fact, patient demographics has a proven impact on health outcomes. Listen in as CancerBuzz speaks to Mary W. Dunn, MSN, RN, OCN, NP-C, Adult Nurse Practitioner of Urology and Medical Oncology at the UNC Lineberger Comprehensive Cancer Center and Samuel L. Washington III, MD, MAS, Assistant Professor of Urology at the University …
It is important for the cancer team to be able to recognize what a small cell might look like — such as central location of the tumor, bulky adenopathy generally.
This cancer program used a business intelligence-enabled dashboard to collect and analyze data on emergency department (ED) visits, admits, and discharges.
In this episode, CANCER BUZZ speaks with Farrukh T. Awan, MD, MS, professor of Internal Medicine and director of Lymphoid Malignancies at the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, about their approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia.
"Many caregivers have it together, they’re on top of everything. They are organized, they are experts at this, but they are falling apart inside. You aren’t going to know if you don’t ask."
Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment. After a successful onboarding, this navigator is now the point person to help identify patients appropriate for clinical trials and to help busy clinicians with enrollment criteria and trial selection.
Lipson Cancer Institute adapted the University of Washington’s Collaborative Care model to embed counseling services into oncology and palliative care across 6 clinic locations.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.